论文部分内容阅读
This issue begins with a systematic review and metaanalysis by Zheng and colleagues[1]about the use of a traditional Chinese medicine–Huperzine A（HupA）–as an adjunctive treatment for depression.The rationale for this treatment is that acetylcholinesterase